Analysis of Radiopharmaceuticals Market / Nuclear Medicine Industry in New Research Report at ReportsnReprots.com

Share Article

“Nuclear Medicine / Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017” is new market research report added to ReportsnReports.com store.

North America is the dominant market for diagnostic radioisotopes with 49% share.

Past News Releases

RSS

The global radiopharmaceuticals market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

“A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, North America, Japan, the Republic of Korea, and Oceania between 2010 and 2030.” Radiopharmaceuticals in neurological applications such as Alzheimer’s disease, Parkinson’s disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers.

The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects; radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.

North America is the dominant market for diagnostic radioisotopes with 49% share (http://www.reportsnreports.com/reports/232420-nuclear-medicine-radiopharmaceuticals-spect-pet-radioisotopes-technetium-f-18-beta-alpha-radiation-therapy-i131-y-90-applications-cancer-oncology-cardiac-stable-isotopes-deuterium-c-13-market-global-trends-forecast-to-2017.html) . The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Covidien, Plc (Ireland), GE Healthcare (U.K.), IBA Group (Belgium), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Siemens Healthcare (PETNET) (Germany).

The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) (U.S.) and Isotec (Sigma Aldrich) (U.S.) - in 2012; they jointly contributed more than 90% to the global revenue.

Scope of the Report
The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global Radiopharmaceuticals Market
Diagnostic
SPECT: Tc-99m, Tl-201, Ga-67, I-123 and Others
PET: F-18, Rb-82 and Others

Therapy
Beta emitters: I-131, Sm-153, Re-186, Y-90, Lu-177 and others

Alpha emitters
Brachytherapy: Cs-131, I-125, Pd-103, Ir-192 and Others
Global Enriched Stable Isotopes Market: Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Others

Radiopharmaceutical and Stable Isotope Markets, By Geography

  •     North America
  •     Europe, including Russia
  •     Asia
  •     RoW (Africa, LATAM, Middle-East, Pacific countries)

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=232420.

Major Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments): Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, Ge Healthcare (Subsidiary Of General Electric Company), Iba Group, Isotec, Inc. (Sigma-Aldrich), Lantheus Medical Imaging, Inc., Nordion, Inc., Ntp Radioisotopes (Pty), Ltd., Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, Ltd., Inc., Australian Nuclear Association And Technology Organization (Ansto), Board Of Radiation And Isotope Technology (Brit), Institute Of Atomic Energy Polatom Radioisotope Centre, Institute Of Isotopes Co., Ltd., Institute Of Radioelement (Ire)

Explore more reports on Pharmaceutical Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us
ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Priyank
Follow us on
Visit website